Direct evidence that the brain reward system is involved in the control of scratching behaviors induced by acute and chronic itch.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 03 11 2020
accepted: 09 11 2020
pubmed: 23 11 2020
medline: 20 4 2021
entrez: 22 11 2020
Statut: ppublish

Résumé

In the present study, we demonstrated that there is a direct relationship between scratching behaviors induced by itch and functional changes in the brain reward system. Using a conditional place preference test, the rewarding effect was clearly evoked by scratching under both acute and chronic itch stimuli. The induction of ΔFosB, a member of the Fos family of transcription factors, was observed in dopamine transporter (DAT)-positive dopamine neurons in the ventral tegmental area (VTA) of mice suffering from a chronic itch sensation. Based on a cellular analysis of scratching-activated neurons, these neurons highly expressed tyrosine hydroxylase (TH) and DAT genes in the VTA. Furthermore, in an in vivo microdialysis study, the levels of extracellular dopamine in the nucleus accumbens (NAcc) were significantly increased by transient scratching behaviors. To specifically suppress the mesolimbic dopaminergic pathway using pharmacogenetics, we used the TH-cre/hM4Di mice. Pharmacogenetic suppression of mesolimbic dopaminergic neurons significantly decreased scratching behaviors. Under the itch condition with scratching behaviors restricted by an Elizabethan collar, the induction of ΔFosB was found mostly in corticotropin-releasing hormone (CRH)-containing neurons of the hypothalamic paraventricular nucleus (PVN). These findings suggest that repetitive abnormal scratching behaviors under acute and chronic itch stimuli may activate mesolimbic dopamine neurons along with pleasant emotions, while the restriction of such scratching behaviors may initially induce the activation of PVN-CRH neurons associated with stress.

Identifiants

pubmed: 33220930
pii: S0006-291X(20)32067-2
doi: 10.1016/j.bbrc.2020.11.030
pii:
doi:

Substances chimiques

Dopamine Plasma Membrane Transport Proteins 0
Histamine 820484N8I3
Tyrosine 3-Monooxygenase EC 1.14.16.2
Picryl Chloride Z4ZG7O5SZ9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-631

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Takao Setsu (T)

Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Yusuke Hamada (Y)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, Japan.

Daisuke Oikawa (D)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Tomohisa Mori (T)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Yozo Ishiuji (Y)

Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.

Daisuke Sato (D)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Michiko Narita (M)

Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, Japan; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.

Shogo Miyazaki (S)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Eri Furuta (E)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Yukari Suda (Y)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, Japan.

Hiroyasu Sakai (H)

Department of Biomolecular Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.

Takahiro Ochiya (T)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.

Hiroyuki Tezuka (H)

Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Aichi, Japan.

Masako Iseki (M)

Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Eiichi Inada (E)

Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Akihiro Yamanaka (A)

Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Aichi, Japan.

Naoko Kuzumaki (N)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan. Electronic address: n-kuzumaki@hoshi.ac.jp.

Minoru Narita (M)

Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, Japan. Electronic address: narita@hoshi.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH